Literature DB >> 22823433

Different peripheral neuroendocrine responses to Trypanosoma cruzi infection in mice lacking adaptive immunity.

Eduardo Roggero1, Johannes Wildmann, Marcelo O Passerini, Adriana del Rey, Hugo O Besedovsky.   

Abstract

Trypanosoma cruzi infection in mice triggers neuroendocrine responses that affect the course of the disease. To analyze the contribution of adaptive immunity to these responses, comparative studies between normal C57Bl/6J and recombinase activator gene 1 (RAG-1)-deficient mice, which lack mature B and T lymphocytes, were performed. There was no difference between both types of mice in basal body weight. Following infection, higher parasitemia, increased IL-1β and IL-6 blood levels, less marked changes in lymphoid organs weight, no cardiomegaly, and earlier mortality were observed in RAG-1-deficient, compared with normal mice. The response of the hypothalamus-pituitary-adrenal axis after infection occurred earlier and was more intense in RAG-1-deficient mice than in normal mice. Noradrenaline concentration and serotonergic metabolism in the spleen, lymph nodes, and heart differed between RAG-1-deficient and normal mice. Our studies indicate that the absence of adaptive immunity to T. cruzi influences the neuroendocrine response to the infection with this parasite.
© 2012 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22823433     DOI: 10.1111/j.1749-6632.2012.06645.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  2 in total

Review 1.  Immune responses against protozoan parasites: a focus on the emerging role of Nod-like receptors.

Authors:  Prajwal Gurung; Thirumala-Devi Kanneganti
Journal:  Cell Mol Life Sci       Date:  2016-03-31       Impact factor: 9.261

2.  DNA Vaccine Treatment in Dogs Experimentally Infected with Trypanosoma cruzi.

Authors:  Minerva Arce-Fonseca; Ana C Carbajal-Hernández; Mónica Lozano-Camacho; Silvia Del C Carrillo-Sánchez; Francisco-Javier Roldán; Alberto Aranda-Fraustro; José Luis Rosales-Encina; Olivia Rodríguez-Morales
Journal:  J Immunol Res       Date:  2020-05-05       Impact factor: 4.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.